← back to search

Tiansheng Shen

University of Alabama at Birmingham · US
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Breast cancer, Medicine, Oncology, Cancer, Internal medicine, and Triple-negative breast cancer.
h-index
citations
568
works
11
NIH funding
primary concept
email

Recent publications

TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma
Human Pathology 2022cited by 76position: middledoi
The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer
Human Pathology 2017cited by 135position: middledoi
Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone
Human Pathology 2017cited by 57position: middledoi
Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important
Human Pathology 2017cited by 25position: firstdoi
A microscopic landscape of the invasive breast cancer genome
Scientific Reports 2016cited by 54position: middledoi
Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer
American Journal of Clinical Pathology 2016cited by 50position: firstdoi
<i>ERBB2</i> mutation is associated with a worse prognosis in patients with <i>CDH1</i> altered invasive lobular cancer of the breast
Oncotarget 2016cited by 46position: middledoi
Clinicopathologic factors associated with de novo metastatic breast cancer
Pathology - Research and Practice 2016cited by 22position: firstdoi
Characterization of estrogen receptor–negative/progesterone receptor–positive breast cancer
Human Pathology 2015cited by 43position: firstdoi
Sinonasal renal cell–like adenocarcinomas: robust carbonic anhydrase expression
Human Pathology 2015cited by 36position: firstdoi
Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis
Pathology - Research and Practice 2015cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gene P. Siegal · University of Alabama at Birmingham9 papers (2015–2017)Shi Wei · University of Alabama at Birmingham7 papers (2015–2017)Margaret Brandwein‐Gensler · University of Alabama at Birmingham2 papers (2015–2015)Dejun Shen · University of Alabama at Birmingham2 papers (2016–2016)Kui Zhang · University of Alabama at Birmingham2 papers (2016–2017)Isam‐Eldin Eltoum · University of Alabama at Birmingham2 papers (2016–2016)Omar Hameed · University of Alabama at Birmingham2 papers (2015–2015)Dongquan Chen · University of Alabama at Birmingham2 papers (2016–2016)Bryce Parkinson · The Ohio State University1 papers (2022–2022) · 1 papers (2022–2022)Lester D.�R. Thompson · Woodland Hills Medical Center1 papers (2015–2015)Constance T. Albarracin · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Xiao Huang · University of Alabama at Birmingham1 papers (2022–2022)Vishwas Parekh · City Of Hope National Medical Center1 papers (2016–2016)Ayşegül A. Şahin · The University of Texas Health Science Center at Houston1 papers (2022–2022)Naser M. Ali · University of Birmingham1 papers (2017–2017)Jianbo He · China XD Group (China)1 papers (2016–2016)Lavinia P. Middleton · University of Houston1 papers (2022–2022) · 1 papers (2017–2017)Shuko Harada · University of Alabama at Birmingham1 papers (2016–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →